News Room
August 30, 2010
Millennium Announced today the appointment of David Cohen to Chief Operating Officer. In his capacity as COO.
August 9, 2010
Millennium Announced today a national agreement with MultiPlan, the nation's leading comprehensive provider of healthcare cost management solutions.
July 27, 2010
Millennium urges Medicare to Reconsider the 2010 Physician Reimbursement for Point-of-Care Urine Drug Screen Devices.
July 12, 2010
James Slattery has donated $2 million to the University of Washington.
June 7, 2010
James Slattery Joins Angel Flight West.
May 4, 2010
Millennium Laboratories Announces New President Howard Appel.
March 08, 2010
Alun Malone Joins Millennium Laboratories As New Business Development Executive.
February 22, 2010
Millennium Laboratories Announces National Agreement with Aetna for Pain Management Services.
February 01, 2010
Millennium Laboratories Applauds Panel's Decision to Revise Proposed Florida Rule for Clinical Lab Testing.
-Back to News Room-
Millennium Laboratories Research Study Reveals Lower Opiate Cutoff Levels Identify Higher Percentage of Patients Taking Illegal Drugs
SAN DIEGO, CA – February 22, 2010 – Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation’s leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories’ will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools. These will help physicians better manage their patients’ pain while at the same time aiding compliance with pain medication regimens.
James Slattery, Millennium Laboratories CEO, commented, “We are proud to have been selected by Aetna as a national pain management services provider. Aetna’s support of therapeutic drug monitoring services for their participating physicians advances urine drug screening as a standard of care to ensure patients have quality pain management. As a leader in this field, pain physicians know they can rely on Millennium Laboratories as we provide the fastest turn-around time in the industry for drug test reporting and final confirmation of results because we exclusively utilize the latest cutting-edge technology, Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS).”
About Millennium Laboratories
Founded in 2007 in America's biotech capital, San Diego, Millennium Laboratories is rapidly becoming the Urine Drug Testing (UDT) resource of choice for physicians and staff focused on the treatment of chronic pain. Millennium Laboratories provides the fastest turn-around time in the industry for drug test reporting and final confirmation of results because the company is the only major Urine Testing Laboratory exclusively utilizing the latest cutting-edge technology Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS). The company is also the only major Urine Drug Testing Laboratory licensed as a training facility for Toxicology Scientists.
Certified, state-of-the-art advanced training at Millennium’s 40,000 sq. ft. campus is an integral component of the University of California, San Diego’s (UCSD) doctoral program in Pharmacy. Led by Laboratory Director Amadeo Pesce, Ph.D., world-renowned Toxicologist and author, the Millennium Laboratories team are experts in mass spectrometry and high throughput chemistry. The company has developed proprietary methodologies that provide the fastest reliable urine drug testing (UDT) confirmations in the nation, usually within one business day. For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.
###
Millennium Laboratories Contact:
Renee Bryan, Vice President of Marketing
Millennium Laboratories
877-451-3534
rbryan@becausepainmatters.com
Media Contact:
Sandra G. Oak
Nsight Public Relations
321-591-1508
soak@nsightpr.com